Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Maue

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Frontiers in Cellular and Infection Microbiology|September 17, 2021
Exploring Changes in the Host Gut Microbiota During a Controlled Human Infection Model for <i>Campylobacter jejuni</i>Blake W Stamps, Janelle Kuroiwa, Sandra D Isidean, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2017
Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled TrialJoanna E Rimmer, Clayton Harro, David A Sack, et al.
Vaccine|October 2, 2018
Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and ShigellaRenee M Laird, Zuchao Ma, Nelum Dorabawila, et al.
Nature Microbiology|March 29, 2018
Campylobacter jejuni transcriptional and genetic adaptation during human infectionAlexander A Crofts, Frédéric M Poly, Cheryl P Ewing, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Frontiers in Cellular and Infection Microbiology|September 17, 2021
Exploring Changes in the Host Gut Microbiota During a Controlled Human Infection Model for <i>Campylobacter jejuni</i>Blake W Stamps, Janelle Kuroiwa, Sandra D Isidean, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2017
Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled TrialJoanna E Rimmer, Clayton Harro, David A Sack, et al.
Vaccine|October 2, 2018
Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and ShigellaRenee M Laird, Zuchao Ma, Nelum Dorabawila, et al.
Nature Microbiology|March 29, 2018
Campylobacter jejuni transcriptional and genetic adaptation during human infectionAlexander A Crofts, Frédéric M Poly, Cheryl P Ewing, et al.
Pageof 3